Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Gut Microbiota by Oral Sialic Acid: A Mechanistic Study

NCT07162662 is registered in ClinicalTrials.gov with Xiaolong Li as lead sponsor.

NCT NCT07162662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07162662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Gut Microbiota by Oral Sialic Acid: A Mechanistic Study
Lead sponsor
Xiaolong Li
Phase
Not applicable
Overall status
Recruiting
Start date
September 10, 2025
Completion date
August 1, 2027
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, taking sialic acid to regulate the gut microbiota